By Kim Hyelin The human immune system, gene editors designed by artificial intelligence (AI), living biological robots and ...

The biotech industry saw reduced IPOs and investment in 2023. Is there reason for optimism? Noubar Afeyan, founder and chief executive officer of Flagship Pioneering, discusses innovations and ...

The healthcare biotechnology sector has been hyped as a future source of economic wealth for South Korea. There is insufficient understanding that life science enterprises take many years to ...

This difference highlights the impact of continuous investment in innovations and emerging technologies like biotechnology.

New drug approvals and pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry despite the uncertain macro environment. A strong portfolio and solid ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

Dan Heapy brings strategic marketing expertise to critically assess the approaches taken by the biotech companies – and offers recommendations for future biotech development. With the ever ...

The situation was reversed only 25 years ago. So, the Biotech Centre of Excellence will project the group towards the future of medicine and science. It is a strong message for Italy, and Parma in ...

India is set to lead the global biotech revolution, with advancements and innovations shaping the future of the industry on a global scale. In 2025, India is set to play a pivotal role in the ...

A group of biotechnology research companies based in Birmingham will receive $44 million in federal funding to research AI technology, federal officials announced this morning. The Birmingham ...